Oct 4
|
IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management
|
Oct 2
|
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2
|
Jul 29
|
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement
|
May 8
|
IM Cannabis Reports First Quarter Financial Results
|
May 1
|
IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET
|
Apr 16
|
IMC to transfer its Oranim Pharmacy shares back to the seller
|
Apr 9
|
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
|
Apr 4
|
Avant and IMC Execute BLK MKTā¢ Trademark Licensing Agreement for the German Medical Cannabis Market
|
Apr 4
|
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
|
Apr 1
|
IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients
|
Mar 28
|
IM Cannabis Reports 2023 Financial Results
|
Mar 25
|
IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization
|
Mar 20
|
IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET
|
Jan 12
|
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition
|
Jan 2
|
IMC Announces the Conclusion of the Planning and Construction Legal Proceedings
|
Dec 8
|
New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in Novem...
|
Nov 27
|
IM Cannabis Announces Receipt of Court Action
|
Nov 13
|
IM Cannabis Reports Third Quarter 2023 Financial Results
|
Nov 8
|
IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET
|
Apr 28
|
IM Cannabis Announces Units for Debt Settlement
|